Abstract: Decellularization removes cellular antigens while preserving the ultrastructure and composition of extracellular matrix (ECM). Decellularized ECM (DECM) scaffolds have been widely used in various tissue engineering applications with varying levels of success. The mechanical, architectural and bioactive properties of a DECM scaffold depend largely on the method of decellularization and dictate its clinical efficacy. This article highlights the advantages and challenges associated with the clinical use of DECM scaffolds. Poor mechanical strength is a significant disadvantage of some DECM scaffolds in the repair of load-bearing tissues as well as critical-size defects, where long-term mechanical support is required for the regenerating tissue. Combining DECM scaffolds with synthetic biocompatible polymers could provide a useful strategy to circumvent the issues of poor mechanical stability. This article reviews studies that have combined DECM scaffolds from various tissues with synthetic polymers to create hybrid scaffolds using electrospinning. These hybrid scaffolds provide a mechanical backbone while retaining the bioactive properties of DECM, thus offering a significant advantage for tissue engineering and regenerative medicine applications.
Introduction
The use of extracellular matrix (ECM) derived from decellularized tissues is an important avenue for tissue engineering and regenerative medicine, overcoming the shortage of donor organs, and issues associated with graft rejection following transplantation. The primary objective of decellularization is the removal of cell associated antigens and preservation of the ultrastructure and composition of the ECM [1] . This acellular approach has the potential to recruit endogenous host cell and prevents the limitations associated with the delivery of exogenous cells such as immunogenicity, inefficient methods of delivery, and apoptosis after delivery [2] . Decellularized ECM (DECM) scaffolds mimic the native tissue composition and possess similar concentrations and ratios of growth factors, basement membrane structural proteins as well as glycosaminoglycans (GAG). DECM scaffolds improve cell growth, migration, differentiation and can positively influence tissue repair and remodeling [3] [4] [5] [6] [7] . DECM from a variety of tissues such as skeletal muscle [8] [9] [10] , brain [11, 12] , urinary bladder [2, 5, 13] , small intestinal submucosa [14] [15] [16] , liver [4, [17] [18] [19] , skin/adipose tissue [20] [21] [22] , blood vessels [23] [24] [25] , heart valves [26, 27] and tendons [28] have been used for tissue engineering applications.
Decellularization protocols typically combine physical and chemical treatments for removal of cellular antigens [29] . Physical methods may include freeze-thawing, mechanical agitation or sonication. Chemical methods can include treatment with ionic or non-ionic detergents and enzymes that are capable of disrupting cell membranes as well as intercellular and extracellular adhesion. The Food and Drug Administration (FDA) has not provided strict guidelines for the decellularization of ECM and the minimum concentration of cellular debris that can elicit an undesirable immune response has also not been established. Since the host tissue response to decellularized materials is dependent on the near complete removal of the cellular remnants and maintenance of native tissue properties, Badylak et al., have suggested that a decellularized matrix should contain negligible DNA content (i.e. below 50 ng/mg of D-ECM dry weight and less than 200 base pair in length) and no visible nuclear material in tissue sections stained with DAPI or H&E [30] .
Decellularization is known to alter the native threedimensional architecture of the ECM, resulting in modified mechanical and biological properties [31] [32] [33] . However, despite this information, criteria for minimum disruption of decellularized ECM's mechanical and bioactive properties have also not been established. For instance, ionic detergents such as sodium dodecyl sulfate (SDS) and enzymatic treatments with trypsin are known to be detrimental to matrix mechanical properties [18] . Potent ionic and enzymatic treatments can reduce the GAG content, disrupt protein-protein interactions, and impair collagen integrity, which results in altered tissue mechanics [19, 31, 34] . Treating tissues with ethanol, methanol, and acetone can result in fixation, cross-linking and precipitation of ECM proteins [35] . While cross-linking would result in a stiffer matrix, the mechanical properties would be very different from native tissues. It has been reported in some studies that combinations of ammonium hydroxide and Triton X-100 effectively decellularizes tissues while preserving the ultrastructure and mechanical properties of the DECM better than other methods [18, 36] . Minimum alterations in the mechanical properties of native tissues are desirable in ECM scaffolds designed for clinical applications. Additionally, if implanted, the DECM scaffold should be strong enough to withstand the harsh chemical and immunological environment typical of traumatic injuries. Furthermore, the DECM scaffold should degrade at a rate that matches new tissue ingrowth. While cellular infiltration and new matrix deposition are likely to remodel and strengthen the implanted DECM scaffold, complete cellularization could take several weeks to months. Therefore, the fabrication of a mechanically robust scaffold prior to implantation is essential for effective tissue regeneration and remodeling.
Clinical Applications of Decellularized ECM Scaffolds
The use of decellularized ECM scaffolds has been translated to the clinic with varying levels of success. 
Clinical use of decellularized matrices
Porcine urinary bladder matrix (UBM) marketed by ACell , Inc. in several structural configurations (e.g. micronized powder, lyophilized or vacuum pressed layered sheets) has been widely used in clinical treatment of extremity wounds. It has been reported that wound treatment with decellularized UBM provides a reasonable alternative to complex surgical procedures, avoids flapassociated donor site morbidity and allows for easier management of patients with comorbidities such as obesity, diabetes mellitus and cardiopulmonary compromise [38, 39] . Three clinical case summaries, based on the experiences of the authors of this review, are presented to demonstrate the efficacy of UBM in treating abdominal wall repair as well as upper and lower extremity wounds. The first case is of a 63-year-old male who developed a large ventral hernia plus rectus abdominis muscle weakness after a liver and kidney transplant 8 years prior (Figure 1A) Figure 1D ). Furthermore, the newly deposited tissue was compliant enough to withstand maximum abdominal straining and there was no palpable hernia defect noted. The second case is of a 21-year-old male who presented with a 10 × 17 × 3.5 cm (595 cm 2 ) forearm gunshot wound which caused severely comminuted proximal ulna and radius fractures (Figure 2A ). After orthopedic plating (Figure 2B Figure 2D ). Parenteral antibiotics were given for 8 weeks until the exposed orthopedic hardware was covered. Tendon transfers to restore absent finger extension were done 6 months later. Two years post treatment, the wound showed complete closure and skin coverage. The patient also showed near normal functional use of the limb in the follow-up exam suggesting constructive remodeling of the injured tissue. The third case is of a 54-year-old male who ran over his right foot while jumping off of his riding lawnmower as it Figure 3D ). The cellular and molecular mechanism of wound healing is still largely unclear in these cases. Although complex wounds managed with UBM may require several applications and prolonged closure time as compared to muscle flaps, the ease of application and post-operative management could provide a great benefit in war-zones and other medically under-resourced areas the world over [38, 39] . Additionally, treatment of wounds with off-the-shelf UBM allows for a short hospitalization time and faster recovery to normal activities.
Clinical challenges associated with decellularized matrices
While some pre-clinical studies and clinical case reports have shown encouraging results with the use of decellu- and Restore TM ) for tendon repair [40, 41] highlighting the need for proper decellularization of these materials and strict FDA guidelines to ensure clinical safety. Other studies have shown that porcine SIS materials do not have the required tensile strength for functional tendon repair [42] . As discussed previously, DECM scaffolds are known to exhibit poor biomechanical properties. In a recent example, the porcine UBM scaffold (MatriStem TM , ACell , Inc.) was found to be completely resorbed without tissue remodeling in a rodent musculotendinous junction defect model, suggesting that the scaffold may not be suitable for certain injuries where long-term mechanical support is required [13] . Additionally, DECM scaffold implantation is often reported to result in scar tissue deposition without sitespecific regeneration of tissues. For instance, in a clinical trial of chronic leg ulcer patients, only 55% of the wounds treated with porcine SIS materials achieved complete closure. Although the use of SIS increased the rate of healing and reduced the incidence of ulcer recurrence, scarless healing and complete regeneration of skin was not observed [43] . In rodent models of traumatic volumetric muscle loss (VML) injuries, DECM scaffolds such as rodent muscle-derived ECM [8, 44] , commercially available SIS-ECM [45] and porcine UBM matrix (MatriStem TM , ACell , Inc.) [13, 46] , did not appreciably regenerate muscle fiber in vivo and remodeled into a fibrotic scar. In a clinical case study by Mase et al., a military service member with traumatic skeletal muscle injury was treated with a porcine SIS scaffold into the defect site that resulted in functional improvement at 16 weeks without significant muscle fiber regeneration [47] . In a recent study by Sicari et al., porcine UBM scaffold (MatriStem TM , ACell , Inc.) implantation in patients with VML resulted in improved stem cell mobilization and force production with severely limited muscle regeneration [2] . Overall, these studies suggest that ECM scaffolds are capable of improving skeletal muscle function with little to no de novo muscle fiber regeneration. In the absence of muscle regeneration, the improvements in muscle function are possibly due to a fibrotic scar mediated mechanical bridging effect that increased force transmission through the myofibers [13, 48, 49] . Since scar tissue lacks the contractile properties of native muscle tissue, it leaves the traumatized muscle susceptible to reinjury. Thus, while DECM scaffolds have the potential to improve wound healing and neovascularization, further evaluation in pre-clinical and clinical studies is needed to establish their efficacy in facilitating scar-free regenerative remodeling of injured tissues. [59]
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PCL/PLGA scaffold with MPC derived DECM 50 mM Tris-HCl, 1 mM NaCl, and 10 mM EDTA, 1% Triton X-100, 1 mg/ml DNase N/A Scaffolds showed improved host integration, reduced immune response and greater angiogenic capacity when implanted subcutaneously in mice.
[71] Concluded
Electrospun scaffolds composed of decellularized matrix proteins
Electrospinning is a useful technology to make tissue engineered scaffolds with tunable structural and biomimetic properties. Next generation tissue engineered scaffolds will utilize hybrid materials that combine the versatility of synthetic polymers with the bioactive properties of natural polymers. Several researchers have created composite scaffolds consisting of DECM and synthetic polymers using the technique of electrospinning. These composite scaffolds have shown superior mechanical properties and maintenance of bioactivity in various tissue engineering applications (Table 1) .
Cardiovascular tissue engineering
The use of synthetic polymers for vascular graft prosthetics is marred by thrombosis, calcification, chronic inflammation and intimal hyperplasia [50] . DECM scaffolds are attractive for cardiovascular engineering applications due to their histocompatibility and antithrombotic properties but pose the risk of aneurysm formation due to poor biomechanical properties [33] . To circumvent these issues, Gong et al. [51] , fabricated a hybrid scaffold composed of an inner layer of decellularized rat aorta and a 100 µm thick outer layer of electrospun polycaprolactone (PCL) nanofibers. Reinforcement of the decellularized aorta with an outer layer of PCL significantly improved the mechanical properties and physical stability. Six weeks after implantation as new abdominal aorta interposition grafts in a rat model, the scaffolds remained satisfactorily patent and did not show any evidence of vasodilation, aneurysm formation or inflammatory reaction. Using a similar approach, Hong et al. [52] , fabricated a decellularized porcine aortic valve leaflet and coated it with a biodegradable poly-4-hydroxybuyrate (P4HB) using electrospinning. The P4HB coating had a reinforcing effect on the decellularized scaffold and these hybrid structures had superior tensile strength and elastic modulus. Freshly isolated mesenchymal stem cells (MSC) were seeded on the hybrid scaffolds and cultured for 14 days. Biochemical and histological analysis showed that the scaffolds supported cellular adhesion, growth and collagen production suggesting that the layer of P4HB did not compromise the excellent bioactive properties of the decellularized scaffold.
Cartilage regeneration
While cartilage tissue has the advantage of being nonimmunogenic, it is very difficult to decellularize. Several cycles of decellularization are needed for the complete removal of chondrocytes, which severely compromises the mechanical integrity of the decellularized tissue [53] . In a recent study, human nasal septum cartilage samples were decellularized using four different protocols and were freeze dried and pulverized to yield DECM particles. The DECM particles (5 mg/ml) were covalently immobilized on the surface of poly (3-hydoxybutyrate) (PHB) / poly(3-hydroxybutyrate-co-3-hydroxy-valerate) (PHBV) electrospun nanofibers using EDC-NHS chemistry. Primary human chondrocytes (hPChs) and adipose derived stem cells (hASC) were cultured on these biofunctional scaffolds for 21 days. The scaffolds supported cell adhesion, growth as well as collagen production and increased chondrogenic marker expression (e.g. Sox 9, collagen II and aggrecan) as shown in Figure 4 [54] .
In another study, decellularized porcine menisci were electrospun in combination with PCL to create random and aligned nanofibrous mats. The solutions of DECM (6% w/w) and PCL (8% w/w) were mixed at ratios of 0:5, 1:4, 2:3, 3:2, 4:1 and 5:0. To further enhance the stability of the matrices they were crosslinked with EDC-NHS. The addition of DECM improved the hydrophilicity, tensile modulus and yield stress of the scaffolds. The tensile moduli of the aligned scaffold matched that of human meniscus. Rabbit meniscus fibrochondrocytes were able to attach and proliferate on these scaffolds and showed a linear increase in the gene expression of chondrogenic markers with increasing concentrations of DECM in the scaffolds [55] .
In a study by Guilak et al., porcine articular cartilage derived ECM (0.08 g/ml) was electrospun with PCL to create single-layered and multilayered scaffolds [56] . Although the pore-size or porosity of the multi-layered scaffolds was not quantified, the authors reported noticeable presence of voids between the layers. Incorporation of cartilage ECM into the scaffolds significantly reduced the Young's modulus and increased the COL10A1 gene expression and GAG synthesis in hASCs. In comparison to a continuously-collected single-layer scaffold, collection of 60 separate layers to form a single multi-layer scaffold enhanced hASC infiltration and ACAN gene expression. The cartilage ECM was obtained by freeze-thaw and pulverization. The authors did not provide any information on the composition of resulting ECM or the removal of cellular remnants, limiting the clinical relevance and scope of this work. It should also be noted that since cartilage tissue primarily resists compressive forces, uniaxial tensile testing of scaffolds typically used for mechanical characterization of electrospun scaffolds offers little relevance to clinical conditions.
Abdominal wall repair
Mechanical failure of implanted biomaterials is a major concern in incisional hernia repair and abdominal wall defects. To improve the elasticity and mechanical characteristic of DECM scaffolds, porcine dermal ECM was combined with poly(ester urethane) urea (PEUU) in varying ratios (15:85, 25:75, 50:50, 0:100) to create composite scaffolds using electrospinning. Increasing concentrations of DECM reduced the mechanical strength of the composite scaffolds [57] . The scaffolds containing 25% DECM and 100% PEUU (control) were used in a rat full thickness abdominal wall replacement model. At 4 and 8 weeks after implantation, the scaffolds showed fibrous encapsulation and minimum cellular infiltration that was restricted to the periphery of the scaffold suggesting limited tissue remodeling. Skeletal muscle regeneration was not observed and only alpha smooth muscle actin positive cells were found on the edges of the scaffold suggesting that this approach was not suitable for muscle regeneration in a fullthickness defect.
In a subsequent study, Wagner et al., modified their design and fabricated a porcine dermal ECM gel-rich layer that was bordered by two supportive PEUU rich outer layers using a concurrent electrospinning/electrospraying technique. These sandwich scaffolds performed better in a full thickness abdominal defect model and showed greater cellular infiltration as well as collagen deposition at 4 and 8 weeks after implantation. In contrast, the control biohybrid scaffolds that lacked the upper and lower PEUU rich layers failed at 8 weeks. However, no substantial skeletal muscle regeneration was observed in any of the tested groups [58] .
Wagner et al., also fabricated electrospun scaffolds of PEUU in combination with decellularized porcine UBM. In comparison to pure UBM scaffolds, composite scaffolds showed continuous and smooth nanofiber morphology, superior mechanical properties and increased resistance to hydrolytic degradation. The UBM containing PEUU scaffolds were able to support greater vascular smooth muscle cell attachment and proliferation in vitro. Increasing concentrations of UBM in hybrid scaffolds increased scaffold degradation and cellular infiltration over 28 days when implanted subcutaneously in vivo [59] .
Neural tissue engineering
The use of ECM scaffolds for neural tissue injury is limited. Recently, DECM matrices have been developed for improving functional recovery after central nervous system (CNS) injury [60, 61] . Baiguera et al., fabricated electrospun scaffolds composed of rat decellularized brain ECM (dBECM, 1% w/w) and gelatin. The scaffolds were crosslinked with genipin for mechanical stability. The scaffolds contained uniform bead free nanofibers that were structurally maintained following genipin cross-linking ( Figure 5 ). Bone marrow derived MSCs were cultured on these scaffolds and tested for differentiation potential. The results showed that dBECM-gelatin composite scaffolds allowed cell adhesion, spreading, proliferation and the formation of multilayered cultures. dBECM-genipin scaffolds also induced significantly higher expression of neural cell markers (e.g. GFAP), suggesting differentiation towards neural/glial lineage [62] .
In another study, porcine cauda equina (4% w/v) was decellularized and mixed with poly (l-lactide-coglycolide) (PLGA) at a weight ratio 70:30 to fabricate scaffolds with random and aligned nanofibers using electrospinning [63] . The DECM was rich in collagen, laminin, fibronectin and GAGs and improved the hydrophilicity of the electrospun scaffolds. Sciatic nerve derived Schwann cells showed significantly higher proliferation on DECM containing scaffolds and exhibited preferential orientation along the direction of nanofibers. The scaffolds containing DECM also stimulated greater neurite extension parallel to that of aligned nanofibers in dorsal root ganglions compared to pure PLGA scaffolds.
Bone tissue engineering
Electrospinning offers the advantage of creating a biomimetic scaffold of any shape or size and is suitable for creating an osteoinductive periosteum replacement that could be tailored to fit the dimension of the targeted bone. Gibson et al. [64] , incorporated decellularized ECM nanoparticles from bone into a biosynthetic nanofiber composite scaffold. Porcine bone ECM was isolated from decalcified femoral diaphysis, cryogenically pulverized and subjected to high pressure homogenization. The resulting bone DECM nanoparticles (~100 nm) were mixed with PCL (10% w/v) and electrospun to create nanofibers [64] . The majority of total protein from PCL-DECM fiber meshes was released in the first four days when samples were incubated in phosphate buffered saline at 37 ∘ C. The hASCs showed adhesion, survival and proliferation on the composite scaffolds. The effect of DECM incorporation on hASC osteogenic differentiation was also evaluated. Pure PCL and composite PCL-DECM scaffolds supported calcified matrix production from hASCs in osteogenic medium. The gene expression of osteogenic markers such as RunX2, osteocalcin and collagen I in hASCs were significantly higher on composite scaffolds compared to pure PCL scaffolds. In this study, the authors also showed that nanoparticles derived from porcine lung and spleen DECM significantly impeded osteogenic differentiation of hASCs, while porcine cartilage and fat DECM supported osteogenic outcomes. Therefore, the tissue source of DECM may regulate site specific differentiation of stem cells and appropriate sources must be considered for specific tissue engineering applications.
Cell derived ECM
A number of studies have used cell-derived ECM for tissue engineering applications. The cell-derived ECM offers the advantage of potentially being patient-specific and thus eliminating the problems of availability and safety, which are associated with decellularized ECM from xenogenic and allogenic tissue sources. In a recent example, following 4 weeks of adult human dermal fibroblasts (hADF) culture on electrospun PCL, the scaffolds were decellularized and milled into a fine powder. This cell-derived DECM powder was mixed with 10% PCL solution to create multilayered three-dimensional scaffolds using the electrohydrodynamic jet process [65] . The tensile properties of the hybrid scaffolds were significantly enhanced compared to pure PCL scaffolds and this result was attributed to the reinforcing components of the cell-derived ECM such as collagen, elastin, GAG etc. Addition of cell derived DECM also enhanced the hydrophilicity of the scaffolds and improved hADF adhesion and metabolic activity. In another study, human adipose derived MSCs were cultured on electrospun silk fibroin scaffolds. Decellularization of cell-seeded scaffolds was performed to collect cell-derived matrix deposited on the silk fibroin meshes. Silk fibroin scaffolds cellularized with MSCs or decellularized were grafted into wounds of diabetic mice. Both scaffolds improved wound healing and tissue regenera-tion and upregulated genes associated with angiogenesis and matrix remodeling [66] . Additionally, both scaffolds were able to promote endothelial cell migration by slightly different mechanisms. While vascular endothelial growth factor (VEGF) was the primary factor released by cellularized silk fibroin scaffolds, fibroblast growth factor (FGF)-2 and transforming growth factor (TGF)-β1 were released by acellular silk fibroin scaffolds. Overall, the study showed that removal of cells from electrospun meshes did not alter the wound healing capacity of the scaffolds.
Shtrichman et al. [67] cultured mesenchymal progenitor cells (MPCs), derived from human embryonic stem cells and human induced pluripotent stem cells for 3-4 weeks on electrospun PCL and PLGA scaffolds. The ECM produced by MPCs on the electrospun meshes was harvested by decellularization. The secreted ECM was primarily composed of collagens and structural proteins such as actin, vimentin, fibronectin and laminin. The electrospun scaffolds with or without cell derived ECM were implanted subcutaneously in mice to evaluate their biocompatibility. The pure PCL and PLGA scaffolds showed high levels of immune response and reduced integration with the host tissue. In contrast, the DECM containing PCL and PLGA scaffolds showed improved integration, reduced immune response, and greater angiogenic capacity in vivo.
Pre-osteoblasts were cultured on electrospun PCL scaffolds for 4 weeks, followed by decellularization to obtain cell derived matrix. The PCL-DECM scaffold was treated with oxygen plasma to obtain a nanoscaleroughened surface of the PCL-DECM nanofibers. The results showed that this topologically designed fibrous structure significantly improved osteoblast proliferation and osteogenic differentiation. Therefore, synergistic effects of biochemical components of DECM and surface topology were able to improve the potential of this hybrid scaffold for hard-tissue regenerative applications [68] .
Taken together, these studies demonstrate that in vitro cell-culture derived ECM is potentially capable of tissue repair and remodeling. These results are encouraging for the use of cell-derived matrix, which if patient-specific, will overcome the risk of disease transmission and immunological reaction commonly associated with xenogenic and allogenic DECM scaffolds. However, more studies are needed to determine the mechanical properties, microstructure and composition of cell-derived ECM. Its efficacy in in vivo models of injury also needs to be demonstrated.
Conclusion
Tissue processing methods and the resulting DECM scaffold's mechanical, architectural and bioactive properties are critical determinants of clinical success. Therefore, caution must be observed when decellularizing tissues to ensure complete removal of cellular remnants, preservation of key components and maintenance of structural and biomechanical properties. Poor mechanical strength is a significant disadvantage of DECM scaffolds in the repair of load-bearing tissues and critical-size defects. Strategies that combine DECM with mechanically durable materials (e.g. synthetic polymeric nanofibers) could be a useful approach to circumvent the issue of mechanical stability and degradation that limit the use of DECM scaffolds in clinical applications. Further evaluation of composite electrospun scaffolds in pre-clinical and clinical studies is needed to establish their efficacy in tissue engineering and regenerative medicine applications.
